The University of Washington School of Medicine is a large public medical school in the northwest United States, located in Seattle and affiliated with the University of Washington.

During the past decade, University of Washington School of Medicine conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 11 clinical trials were completed, i.e. on average, 40.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Washington School of Medicine" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 15 trials, followed by "University of Washington" with 10 trials sponsored, "Celgene" with 5 trials sponsored, "Fred Hutchinson Cancer Center" with 5 trials sponsored and "Bristol-Myers Squibb" with 5 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Washington School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "University of Washington" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "University of Washington School of Medicine" are "HIV Infections" (15 trials), "Prostate Cancer" (7 trials), "Ovarian Cancer" (6 trials), "Lung Cancer" (4 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "University of Washington School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Washington School of Medicine" are "Drug" (56 trials), "Biological" (17 trials), "Procedure" (9 trials), "Behavioral" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "carboplatin" (4 trials), "conventional surgery" (4 trials), "docetaxel" (4 trials) and "GED-0301" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Washington School of Medicine" are 60 trials for "All" genders, 11 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 15 active trials in "University of Washington School of Medicine". 1 are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in University of Washington School of Medicine, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in University of Washington School of Medicine, 19 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".